Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-9966

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors ; volume:29 ; number:1 ; day:15 ; month:7 ; year:2010 ; pages:1-8 ; date:12.2010
Journal of experimental & clinical cancer research ; 29, Heft 1 (15.7.2010), 1-8, 12.2010

Creator: Caenepeel, Sean
Renshaw-Gegg, Lisa
Baher, Angelo
Bush, Tammy L.
Baron, Will
Juan, Todd
Manoukian, Raffi
Tasker, Andrew S.
Polverino, Anthony
Hughes, Paul E.

Contributor: SpringerLink (Online service)

DOI: 10.1186/1756-9966-29-96

URN: urn:nbn:de:101:1-2021082220492530566339

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Caenepeel, Sean
Renshaw-Gegg, Lisa
Baher, Angelo
Bush, Tammy L.
Baron, Will
Juan, Todd
Manoukian, Raffi
Tasker, Andrew S.
Polverino, Anthony
Hughes, Paul E.
SpringerLink (Online service)

Other Objects (12)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis

Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

Related objects

Reset password